09.02.2013 Views

2009 Form 990-PF - Bill & Melinda Gates Foundation

2009 Form 990-PF - Bill & Melinda Gates Foundation

2009 Form 990-PF - Bill & Melinda Gates Foundation

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

BILL & MELINDA GATES FOUNDATION 56-2618866<br />

FORM <strong>990</strong><strong>PF</strong>, PART XV - GRANTS AND CONTRIBUTIONS PAID DURING THE YEAR<br />

RELATIONSHIP TO SUBSTANTIAL CONTRIBUTOR<br />

AND<br />

ATTACHMENT 18 (CONT'D)<br />

RECIPIENT NAME AND ADDRESS FOUNDATION STATUS OF RECIPIENT PURPOSE OF GRANT OR CONTRIBUTION AMOUNT<br />

OFFICE OF CONTRACT AND GRANTS 509(A)(1)<br />

LA JOLLA, CA 920930934<br />

ANTI-MALARIAL STRATEGIES, INCLUDING DRUGS AND<br />

VACCINES.<br />

REGENTS U OF CALIFORNIA SAN DIEGO NONE KAILASH PATRA OF THE UNIVERSITY OF CALIFORNIA,<br />

100,000.<br />

OFFICE OF CONTRACT AND GRANTS 509(A)(1)<br />

LA JOLLA, CA 920930934<br />

SAN DIEGO IN THE U.S. WILL USE PROTEOMICS TO<br />

EXAMINE GAMETOCYTE, ZYGOTE, OR OOKINETE<br />

SURFACE PROTEINS OF THE MALARIA PARASITE TO<br />

TEST THEIR REACTIVITY TO HUMAN SERUM COLLECTED<br />

FROM MALARIA ENDEMIC REGIONS, AND TO IDENTIFY<br />

NEW ANTIGEN CANDIDATES FOR MALARIA VACCINES.<br />

REGENTS U OF CALIFORNIA SAN DIEGO NONE KATE EDWARDS OF UNIVERSITY OF CALIFORNIA, SAN<br />

100,000.<br />

OFFICE OF CONTRACT AND GRANTS 509(A)(1)<br />

LA JOLLA, CA 920930934<br />

DIEGO IN THE U.S. WILL TEST THE THEORY THAT<br />

BRIEF BOUTS OF EXERCISE CONSISTING OF CYCLING<br />

AND WEIGHT LIFTING WILL INCREASE ANTIBODY AND<br />

CELL-MEDIATED RESPONSES TO A PNEUMOCOCCAL<br />

VACCINATION ADMINISTERED IMMEDIATELY AFTER THE<br />

PHYSICAL ACTIVITY.<br />

REGENTS U OF CALIFORNIA SAN DIEGO NONE HIGHLY INFECTIOUS "SUPERSPREADERS" OFTEN DRIVE<br />

100,000.<br />

OFFICE OF CONTRACT AND GRANTS 509(A)(1)<br />

LA JOLLA, CA 920930934<br />

FOR PUBLIC DISCLOSURE<br />

221 OF 519<br />

THE SPREAD OF INFECTIOUS AGENTS BUT ARE DIFFICULT<br />

TO IDENTIFY AND TREAT. LEOR S. WEINBERGER OF<br />

UCSD AND JAMES LLOYD-SMITH OF UCLA WILL DEVELOP<br />

AND TEST ENGINEERED PSEUDOVIRUSES CALLED<br />

THERAPEUTIC INFECTIOUS PARTICLES (TIPS), WHICH<br />

CONDITIONALLY REPLICATE ALONG WITH THE PATHOGEN<br />

AS IT SPREADS THROUGH POPULATIONS, BUT HAVE<br />

THEIR VIRULENCE ELEMENTS REPLACED WITH<br />

THERAPEUTIC ELEMENTS THAT SLOW DOWN DISEASE<br />

PROGRESSION AND CURTAIL TRANSMISSION.<br />

ATTACHMENT 18

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!